Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis

ABSTRACT Objective: To explore the feasibility of 68Ga-PSMA PET/CT in diagnosing primary prostate cancer. Materials and Methods: Embase, PubMed and Cochrane Library databases were searched for studies published before July 2020. The studies that used 68Ga-PSMA PET/CT for detecting primary prostate...

Full description

Bibliographic Details
Main Authors: Xianwen Hu, Yan Wu, Peiqing Yang, Ju Wang, Pan Wang, Jiong Cai
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2022-11-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000600891&tlng=en
_version_ 1798018859501879296
author Xianwen Hu
Yan Wu
Peiqing Yang
Ju Wang
Pan Wang
Jiong Cai
author_facet Xianwen Hu
Yan Wu
Peiqing Yang
Ju Wang
Pan Wang
Jiong Cai
author_sort Xianwen Hu
collection DOAJ
description ABSTRACT Objective: To explore the feasibility of 68Ga-PSMA PET/CT in diagnosing primary prostate cancer. Materials and Methods: Embase, PubMed and Cochrane Library databases were searched for studies published before July 2020. The studies that used 68Ga-PSMA PET/CT for detecting primary prostate cancer, and pathological biopsy as the reference standard were included. The selecting process used preferred reporting items for systematic reviews and meta-analyses (PRISMA). The quality of enrolled studies was assessed by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Results: According to our search strategy, 9 studies were included for analysis. A total of 547 patients with primary prostate cancer and 443 lesion segments that underwent 68Ga-PSMA PET/CT scans were included and their pathological biopsies were compared. The results of these studies showed some differences. For instance, the lowest sensitivity of 68Ga-PSMA PET/CT in diagnosing primary prostate cancer was 67%, while the highest sensitivity recorded was 97%. Conclusions: Compared with conventional imaging examinations, 68Ga-PSMA PET/CT had higher sensitivity and specificity in detecting primary prostate cancer. At present, most of the studies that used 68Ga-PSMA PET/CT for detecting prostate cancer are retrospective studies. Based on its advantage of high detection rate, the use of 68Ga-PSMA PET/CT in the detection of primary prostate cancer is worthy of promotion.
first_indexed 2024-04-11T16:30:07Z
format Article
id doaj.art-29154c1827ee4047b48a07a4d37f8381
institution Directory Open Access Journal
issn 1677-6119
language English
last_indexed 2024-04-11T16:30:07Z
publishDate 2022-11-01
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj.art-29154c1827ee4047b48a07a4d37f83812022-12-22T04:14:02ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-61192022-11-0148689190210.1590/s1677-5538.ibju.2020.0986Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysisXianwen HuYan WuPeiqing YangJu WangPan WangJiong Caihttps://orcid.org/0000-0002-0185-445XABSTRACT Objective: To explore the feasibility of 68Ga-PSMA PET/CT in diagnosing primary prostate cancer. Materials and Methods: Embase, PubMed and Cochrane Library databases were searched for studies published before July 2020. The studies that used 68Ga-PSMA PET/CT for detecting primary prostate cancer, and pathological biopsy as the reference standard were included. The selecting process used preferred reporting items for systematic reviews and meta-analyses (PRISMA). The quality of enrolled studies was assessed by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Results: According to our search strategy, 9 studies were included for analysis. A total of 547 patients with primary prostate cancer and 443 lesion segments that underwent 68Ga-PSMA PET/CT scans were included and their pathological biopsies were compared. The results of these studies showed some differences. For instance, the lowest sensitivity of 68Ga-PSMA PET/CT in diagnosing primary prostate cancer was 67%, while the highest sensitivity recorded was 97%. Conclusions: Compared with conventional imaging examinations, 68Ga-PSMA PET/CT had higher sensitivity and specificity in detecting primary prostate cancer. At present, most of the studies that used 68Ga-PSMA PET/CT for detecting prostate cancer are retrospective studies. Based on its advantage of high detection rate, the use of 68Ga-PSMA PET/CT in the detection of primary prostate cancer is worthy of promotion.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000600891&tlng=enProstate-Specific AntigenProstatic NeoplasmsPositron Emission Tomography Computed Tomography
spellingShingle Xianwen Hu
Yan Wu
Peiqing Yang
Ju Wang
Pan Wang
Jiong Cai
Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
International Brazilian Journal of Urology
Prostate-Specific Antigen
Prostatic Neoplasms
Positron Emission Tomography Computed Tomography
title Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
title_full Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
title_fullStr Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
title_full_unstemmed Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
title_short Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
title_sort performance of 68ga labeled prostate specific membrane antigen ligand positron emission tomography computed tomography in the diagnosis of primary prostate cancer a systematic review and meta analysis
topic Prostate-Specific Antigen
Prostatic Neoplasms
Positron Emission Tomography Computed Tomography
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000600891&tlng=en
work_keys_str_mv AT xianwenhu performanceof68galabeledprostatespecificmembraneantigenligandpositronemissiontomographycomputedtomographyinthediagnosisofprimaryprostatecancerasystematicreviewandmetaanalysis
AT yanwu performanceof68galabeledprostatespecificmembraneantigenligandpositronemissiontomographycomputedtomographyinthediagnosisofprimaryprostatecancerasystematicreviewandmetaanalysis
AT peiqingyang performanceof68galabeledprostatespecificmembraneantigenligandpositronemissiontomographycomputedtomographyinthediagnosisofprimaryprostatecancerasystematicreviewandmetaanalysis
AT juwang performanceof68galabeledprostatespecificmembraneantigenligandpositronemissiontomographycomputedtomographyinthediagnosisofprimaryprostatecancerasystematicreviewandmetaanalysis
AT panwang performanceof68galabeledprostatespecificmembraneantigenligandpositronemissiontomographycomputedtomographyinthediagnosisofprimaryprostatecancerasystematicreviewandmetaanalysis
AT jiongcai performanceof68galabeledprostatespecificmembraneantigenligandpositronemissiontomographycomputedtomographyinthediagnosisofprimaryprostatecancerasystematicreviewandmetaanalysis